WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy [Global Data Point]
(Global Data Point Via Acquire Media NewsEdge) WorldCare Clinical, LLC (WCC), a leading imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced that Melissa Gebhardt has been appointed vice president of business development and marketing.
Gebhardt has more than 20 years of experience in medical sales, marketing and corporate strategy, with a specific focus on clinical trial execution and support. She has worked directly with leading pharmaceutical, biotechnology and medical device sponsors to promote medical image management and analysis, patient recruitment and CRO services for global trials. Gebhardt holds a double bachelor's degree in biology and economics from University of California, Santa Cruz.
"The clinical trials landscape is changing rapidly and Melissa's comprehensive background and extensive experience in multiple facets of clinical research services is a valuable asset for WCC," said Richard Walovitch, PhD, president of WorldCare Clinical, LLC.
"I believe that WCC has a unique value proposition with the primary focus being improving assessments for precision and accuracy," stated Gebhardt. "On-time, on-budget delivery is essential, but the distinct added value is in controlling data variability. We are focused on communicating this message through scientific presentations and publications, videos and our new web site, which explains our approach and expands upon our new service offerings, particularly cardiac and malignancy assessment and adjudication services."
(c) 2013 Global Data Point. All Rights Reserved. Provided by Syndigate.info an Albawaba.com company
[ Back To Technology News's Homepage ]